Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × Radiation Dose Hypofractionation × Clear all

NCT06435260 2025-06-26

Hypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic Cancer

Phase 2 Recruiting

Gastrointestinal

Pancreatic Neoplasms